KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for Glomerulonephritis
Laurence H. Beck, Meryl Waldman(National Institutes of Health), Andrew S. Bomback(Columbia University), Howard Trachtman(University of Michigan), Carol A. Langford(Cleveland Clinic), Michael J.G. Somers(Boston Children's Hospital), Michael Choi(Rush University Medical Center), Laura Mariani(University of Michigan)
Cited by 239
Related Papers
Mutations in the chloride channel gene, CLCNKB, cause Bartter's syndrome type III
|Nature Genetics|1997|869
APOL1 Genetic Variants in Focal Segmental Glomerulosclerosis and HIV-Associated Nephropathy
|Journal of the American Society of Nephrology|2011|856
Genetic heterogeneity of Barter's syndrome revealed by mutations in the K+ channel, ROMK
|Nature Genetics|1996|824
MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis
|Nature Genetics|2008|706
Fluid Overload and Mortality in Children Receiving Continuous Renal Replacement Therapy: The Prospective Pediatric Continuous Renal Replacement Therapy Registry
|American Journal of Kidney Diseases|2009|690